The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy
- PMID: 35008381
- PMCID: PMC8750069
- DOI: 10.3390/cancers14010217
The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is still difficult to treat due to insufficient methods for early diagnosis and prediction of therapy response. Furthermore, surveillance after curatively intended surgery lacks adequate methods for timely detection of recurrence. Therefore, several molecules have been analyzed as predictors of recurrence or early detection of PDAC. Enhanced understanding of molecular tumorigenesis and treatment response triggered the identification of novel biomarkers as predictors for response to conventional chemotherapy or targeted therapy. In conclusion, progress has been made especially in the prediction of therapy response with biomarkers. The use of molecules for early detection and recurrence of PDAC is still at an early stage, but there are promising approaches in noninvasive biomarkers, composite panels and scores that can already ameliorate the current clinical practice. The present review summarizes the current state of research on biomarkers for diagnosis and therapy of pancreatic cancer.
Keywords: biomarker; molecular diagnostics; pancreatic ductal adenocarcinoma; targeted therapy.
Conflict of interest statement
L.P. travel expenses: Ipsen, consulting/advisory role: Servier, AstraZeneca. N.S. and T.J.E. declare no conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8750069/bin/cancers-14-00217-g001.gif)
Similar articles
-
Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma.Sci Rep. 2021 Apr 5;11(1):7499. doi: 10.1038/s41598-021-86779-x. Sci Rep. 2021. PMID: 33820913 Free PMC article.
-
Update on the management of pancreatic cancer: surgery is not enough.World J Gastroenterol. 2015 Mar 21;21(11):3157-65. doi: 10.3748/wjg.v21.i11.3157. World J Gastroenterol. 2015. PMID: 25805920 Free PMC article. Review.
-
Dkk1 involvement and its potential as a biomarker in pancreatic ductal adenocarcinoma.Clin Chim Acta. 2019 Jan;488:226-234. doi: 10.1016/j.cca.2018.11.023. Epub 2018 Nov 16. Clin Chim Acta. 2019. PMID: 30452897 Review.
-
Biochemical Predictors of Response to Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma.Front Oncol. 2020 May 12;10:620. doi: 10.3389/fonc.2020.00620. eCollection 2020. Front Oncol. 2020. PMID: 32477933 Free PMC article. Review.
-
Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians.Cancers (Basel). 2021 Mar 3;13(5):1071. doi: 10.3390/cancers13051071. Cancers (Basel). 2021. PMID: 33802340 Free PMC article. Review.
Cited by
-
Cytokine CCL9 Mediates Oncogenic KRAS-Induced Pancreatic Acinar-to-Ductal Metaplasia by Promoting Reactive Oxygen Species and Metalloproteinases.Int J Mol Sci. 2024 Apr 26;25(9):4726. doi: 10.3390/ijms25094726. Int J Mol Sci. 2024. PMID: 38731942 Free PMC article.
-
Editorial: Mechanisms of metastasis from circulating and disseminated tumor cells.Front Cell Dev Biol. 2024 Feb 27;12:1386050. doi: 10.3389/fcell.2024.1386050. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38476261 Free PMC article. No abstract available.
-
Unraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers in patients with pancreatic ductal adenocarcinoma.Front Immunol. 2024 Jan 30;15:1283364. doi: 10.3389/fimmu.2024.1283364. eCollection 2024. Front Immunol. 2024. PMID: 38357542 Free PMC article.
-
Protein Arginine Methylation Patterns in Plasma Small Extracellular Vesicles Are Altered in Patients with Early-Stage Pancreatic Ductal Adenocarcinoma.Cancers (Basel). 2024 Feb 3;16(3):654. doi: 10.3390/cancers16030654. Cancers (Basel). 2024. PMID: 38339405 Free PMC article.
-
KLK10/LIPH/PARD6B/SLC52A3 are promising molecular biomarkers for the prognosis of pancreatic cancer through a ceRNA network.Heliyon. 2024 Jan 7;10(1):e24287. doi: 10.1016/j.heliyon.2024.e24287. eCollection 2024 Jan 15. Heliyon. 2024. PMID: 38234923 Free PMC article.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources